ITGAD

ITGAD (CD11d) encodes the αD subunit of the leukocyte β2 integrin αDβ2 (CD11d/CD18), an adhesion receptor that tunes myeloid cell positioning and inflammatory output at sites of tissue injury and infection (PMID:18621369, PMID:28500072). Surface display of CD11d requires obligate heterodimerization with CD18: the CD11d extracellular domain otherwise drives intracellular retention in the trans-Golgi network, while co-expression of CD18 relieves retention and permits plasma-membrane localization (PMID:19571252). Functionally, αDβ2 acts in a surface-density-dependent manner—at low density it cooperates with β1/β3 integrins to support migration, whereas high density increases adhesiveness and arrests macrophages, promoting their retention at vascular lesions and atherosclerotic plaques rather than altering initial recruitment (PMID:18621369, PMID:28500072). αDβ2 also supports IL-4-induced macrophage fusion into multinucleated giant cells (PMID:27315778) and delivers outside-in signals in human monocytes that drive cell spreading and secretion of inflammatory chemokines and cytokines (PMID:25415295). In vivo, αDβ2 governs leukocyte accumulation across diverse inflammatory and infectious settings—mediating barrier disruption in malaria-associated lung injury (PMID:27473068) and pathogen clearance in Salmonella infection (PMID:29881383)—and on neutrophils it directs a protective, neutrophil-dependent pathway for macrophage lung recruitment and efferocytosis during sepsis and endotoxemia (PMID:33438263). Transcription of CD11d is set by competition at a shared promoter element: Sp1/Sp3 and the myeloid factor TIEG1 activate, while the KLF4 isoform GKLFa recruits HDAC1/2 to repress expression (PMID:10722744, PMID:15087465, PMID:15561714).

1. 2000 High

   Established the basal transcriptional control of CD11d by identifying the core promoter element required for its activity.

   Evidence DNase I footprinting, EMSA, reporter transfection, antisense knockdown and in vivo genomic footprinting of the CD11d promoter

   PMID:10722744

   Open questions at the time

   • Did not address myeloid-specific or inducible regulation
   • Did not connect promoter activity to cell-type expression patterns
2. 2004 High

   Resolved how CD11d transcription is set by competing factors at one promoter element—TIEG1 confers myeloid-specific activation while GKLFa recruits HDACs to repress.

   Evidence Yeast one-hybrid, GST pulldown/EMSA, ChIP, co-IP and siRNA targeting the -61/-44 CD11d promoter region

   PMID:15087465 PMID:15561714

   Open questions at the time

   • Upstream signals controlling the activator/repressor switch not fully defined
   • Did not establish how differentiation triggers HDAC release
3. 2004 Medium

   Tested whether CD11d has a developmental role beyond inflammation, showing a non-redundant T-cell-intrinsic requirement in thymocyte development.

   Evidence CD11d knockout mouse analysis with mixing experiments, flow cytometry and superantigen stimulation

   PMID:15210787

   Open questions at the time

   • Molecular ligand/mechanism in thymocytes not identified
   • Single lab, not independently replicated
4. 2009 High

   Defined the biosynthetic requirement for surface expression, showing CD18 heterodimerization rescues TGN retention driven by the CD11d extracellular domain.

   Evidence YFP/mRFP fusions, confocal microscopy, flow cytometry and CD25 domain-swap mutagenesis in heterologous cells

   PMID:19571252

   Open questions at the time

   • Retention machinery in the TGN not identified
   • Conducted in heterologous cells rather than native myeloid cells
5. 2008 High

   Reconciled migration versus adhesion by showing αDβ2 function is surface-density-dependent.

   Evidence Recombinant HEK293 lines at graded αDβ2 density, macrophage migration assays, anti-αD blockade and an in vivo peritoneal inflammation model

   PMID:18621369

   Open questions at the time

   • Counter-receptors driving the adhesion-dominant state not fully defined
   • Signaling effectors linking density to motility not mapped
6. 2011 High

   Distinguished recruitment from retention, demonstrating αDβ2 arrests macrophages at atherosclerotic lesions rather than affecting their initial entry.

   Evidence CD11d-/-/ApoE-/- atherosclerosis model, adoptive transfer of labeled monocytes, 3D fibrin migration and peritoneal inflammation assays

   PMID:28500072

   Open questions at the time

   • Lesion ligand mediating arrest not identified
   • Relative contribution versus other β2 integrins in vivo unresolved
7. 2011 Low

   Probed a non-macrophage role, implicating neutrophil CD11d/CD18–ICAM-3 cross-talk in co-stimulating NK-cell IFN-γ production.

   Evidence Blocking-antibody experiments with primary human neutrophils and NK cells plus cytokine measurement

   PMID:21712539

   Open questions at the time

   • Interaction inferred from antibody blockade, not directly reconstituted
   • No reciprocal or genetic validation of the ICAM-3 partnership
8. 2014 Medium

   Showed αDβ2 is not merely adhesive but signaling-competent, driving inflammatory gene expression via outside-in signals.

   Evidence Outside-in engagement of αDβ2 on primary human monocytes with gene expression screening and ELISA validation

   PMID:25415295

   Open questions at the time

   • Downstream signaling intermediates not delineated
   • Single lab
9. 2016 Medium

   Extended αDβ2 function to macrophage multinucleation and to lung pathology, establishing roles in giant-cell formation and malaria-associated ARDS.

   Evidence αDβ2-knockout IL-4 macrophage fusion assays and a P. berghei lung-injury model with permeability, cytokine and histology readouts

   PMID:27315778 PMID:27473068

   Open questions at the time

   • Counter-receptor for fusion remains unidentified (ICAM-1-independent)
   • Single labs for each model
10. 2018 Medium

    Demonstrated a protective host-defense role, with αDβ2 required for leukocyte accumulation and pathogen clearance in Salmonella infection.

    Evidence αD-/- mouse peritoneal infection model, macrophage bacterial-killing assay and pyroptosis readouts

    PMID:29881383

    Open questions at the time

    • Mechanism linking αDβ2 to bacterial killing not defined
    • Single lab
11. 2021 High

    Revealed a neutrophil-dependent axis, showing αDβ2 on neutrophils drives macrophage lung accumulation and efferocytosis that is protective in sepsis.

    Evidence αD-/- CLP and LPS endotoxemia models with adoptive-transfer rescue using WT neutrophils versus monocytes and survival analysis

    PMID:33438263

    Open questions at the time

    • Molecular signal by which neutrophils recruit macrophages unresolved
    • Ligand/counter-receptor for neutrophil αDβ2 not identified
12. 2022 Medium

    Added a post-transcriptional layer of regulation, with the lncRNA LINC02190 suppressing ITGAD expression and cell adhesion.

    Evidence Reporter cis-element mapping plus LINC02190 overexpression/knockdown with adhesion assays in Ishikawa/JAR cells

    PMID:35038314

    Open questions at the time

    • Mechanism of LINC02190 action at the ITGAD locus not detailed
    • Relevance to myeloid αDβ2 biology untested
13. 2024 Low

    Characterized a conformation-independent anti-CD11d antibody and noted a total-versus-surface CD11d/CD18 expression mismatch unaltered by CK2 inhibition.

    Evidence Flow cytometry/western blot on primary human leukocytes and THP-1 cells with biochemical signaling assays and a rat SCI model

    PMID:39839909

    Open questions at the time

    • Mechanism of surface-expression mismatch not resolved
    • Limited mechanistic depth; primarily antibody characterization

• The physiological counter-receptors and downstream signaling effectors that distinguish αDβ2-mediated arrest, fusion, and protective recruitment remain unidentified.
• No defined ligand for macrophage arrest at lesions or for fusion
• Outside-in signaling intermediates unmapped
• Mechanism of neutrophil-to-macrophage relay in sepsis unknown